These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17005349)

  • 1. MR contrast agents, the old and the new.
    Bellin MF
    Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted contrast agents in MR imaging.
    Gupta H; Weissleder R
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):171-84. PubMed ID: 8673713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast agents for functional and cellular MRI of the kidney.
    Grenier N; Pedersen M; Hauger O
    Eur J Radiol; 2006 Dec; 60(3):341-52. PubMed ID: 16973326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular gadolinium-based contrast media: differences in diagnostic efficacy.
    van der Molen AJ; Bellin MF
    Eur J Radiol; 2008 May; 66(2):168-74. PubMed ID: 18372137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environment-sensitive and enzyme-sensitive MR contrast agents.
    Querol M; Bogdanov A
    Handb Exp Pharmacol; 2008; (185 Pt 2):37-57. PubMed ID: 18626598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents for MR imaging of the liver.
    Balci NC; Semelka RC
    Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR contrast agents: physical and pharmacologic basics.
    Lin SP; Brown JJ
    J Magn Reson Imaging; 2007 May; 25(5):884-99. PubMed ID: 17457803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C
    Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contrast media in hepatic MRI].
    Grellet J; Bellin MF; Dion E
    J Radiol; 1992 Oct; 73(10):495-9. PubMed ID: 1294722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
    Idée JM; Port M; Dencausse A; Lancelot E; Corot C
    Radiol Clin North Am; 2009 Sep; 47(5):855-69, vii. PubMed ID: 19744600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular gadolinium contrast agents: differences in stability.
    Morcos SK
    Eur J Radiol; 2008 May; 66(2):175-9. PubMed ID: 18343072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-based magnetic resonance imaging contrast agents in interventional radiology.
    Atar E
    Isr Med Assoc J; 2004 Jul; 6(7):412-4. PubMed ID: 15274532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs).
    Querol M; Bogdanov A
    J Magn Reson Imaging; 2006 Nov; 24(5):971-82. PubMed ID: 17024658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of magnetic resonance contrast media on the activity of histamine inactivating enzymes.
    Kuefner MA; Feurle J; Uder M; Bautz W; Schwelberger HG
    Acad Radiol; 2009 Mar; 16(3):358-62. PubMed ID: 19201365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
    Mohs AM; Lu ZR
    Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.